Monday Nov 16 | Gouverneur Times
Prevacid Patent Expires; Could Save Upstate NY'ers millions
Upstate New Yorkers who take the brand-name prescription drug Prevacid for treating heartburn and acid reflux have a significant opportunity to save by switching to the drug's generic equivalent or over-the-counter version now that the Prevacid patent has expired, according to Excellus BlueCross BlueShield .
Monday Nov 16 | Drug Store News
PRINCETON,A N.J The generics arm of Swiss pharmaceutical company Novartis has launched an authorized generic version of a gastroesophageal reflux disease drug.
FDA approves generic gastroesophageal reflux disease treatments
PITTSBURGH The Food and Drug Administration has given two companies approval for a generic version of a drug used to treat gastroesophageal reflux disease.
A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/10/09, Teva Pharmaceutical Industries Ltd.
Video: Novartis Launches Prevacid(R)24HR Over-the-Counter for Full...
Novartis announced the availability of PrevacidA 24HR over-the-counter in pharmacies and retail stores across the US to treat frequent heartburn.
Teva Receives Favorable Court Decision Regarding Generic Prevacid(R) SoluTab
Main Category: Litigation / Medical Malpractice Also Included In: Pharma Industry / Biotech Industry Article Date: 11 Nov 2009 Teva Pharmaceutical Industries Ltd.
Mylan Receives FDA Approval for Generic Version of Prevacid Through...
Mylan Inc. has announced that its privately held Indian subsidiary, Matrix Laboratories Limited, has received final approval from the U.S. Food and Drug Administration for its Abbreviated New Drug Application for Lansoprazole Delayed-release Capsules, 15 mg and 30 mg.
New Study Results Analyzed The Use Of KAPIDEX(TM) (dexlansoprazole)...
New Study Results Analyzed The Use Of KAPIDEX For Nighttime Heartburn In Adults With Non-Erosive GERD Main Category: Acid Reflux / GERD Also Included In: Clinical Trials / Drug Trials ; Pharma Industry / Biotech Industry Article Date: 27 Oct 2009 - 1:00 PDT New data being presented at the American College of Gastroenterology 2009 Annual Scientific ...
New combination therapy looks promising against ulcer bacteria
Helicobater pylori , a bacteria implicated in peptic ulcers and gastritis, was eradicated in 95 percent patients who took a 7-day course of combination therapy with levofloxacin, omeprazole, nitazoxanide and doxycycline compared to eradication in only 80.9 percent of patients on lansoprazole, amoxicillin and clarithromycin for seven days.
Medication Update Benzyl alcohol combats head lice A new prescription medication for the treatment of head-lice infestation has been approved by the FDA for patients age 6 months and older.
Medication Update Benzyl alcohol combats head lice A new prescription medication for the treatment of head-lice infestation has been approved by the FDA for patients age 6 months and older.
Metabolic disposition of lansoprazole in relation to the...
NEW Abstract OBJECTIVE: To assess the possible involvement of CYP2C19 in the metabolism of lansoprazole in vivo.
Plavix doesn't mix well with some heartburn meds
For heart disease, stroke patients and people at risk of a stroke, the clot-preventing drug Plavix is a lifesaver.
Lansoprazole 15 mg Once Daily for 14 Days Is Effective for Treatment of Frequent Heartburn
Fast-Track peer review is available for those papers requiring immediate review .
Original Research: Lansoprazole, Ranitidine, and Metoclopramide:...
Nursingcenter.com Exclusively searches the complete text articles from the 50 leading nursing journals available on NursingCenter, including more than 900 continuing education activities, clinical resources and drug updates contained within this website.
Efficacy of a 7-day course of furazolidone, levofloxacin, and...
Increasing resistance to clarithromycin and nitroimidazole is the main cause of failure in the Helicobacter pylori eradication.
Upcoming FDA Decisions and Clinical Trials: Prevacid Goes OTC, Swine Flu Test
Below is a summary of updates to the BioMedReports.com database of over 200 entries included in the FDA and Clinical Trial Calendars .
Novartis Receives FDA Approval to Market Prevacid(R) 24HR as First...
Novartis has announced that Prevacid 24HR has been approved by the FDA as the first OTC Proton Pump Inhibitor for the treatment of frequent heartburn since 2003.
Chronic diarrhea unresponsive to conventional medication: Are you taking lansoprazole?
Lansoprazole is a proton pump inhibitor which powerfully suppresses gastric acid production and is widely prescribed for chronic use in gastroesophageal reflux disease.
More Evidence of Problems With PPIs and Plavix
A new study has added to the concern that commonly used proton-pump inhibitors may interfere with Plavix in people who have coronary artery disease.
Also on Topix